Cargando…
The early outcomes of candidates with portopulmonary hypertension after liver transplantation
BACKGROUND: Portopulmonary hypertension (PPH) was once regarded as a contraindicaton to liver transplantation (LT). However, growing evidence has indicated that PPH patients undergoing LT may show similar outcomes compared to those without PPH, and researchers have recommended it not be an absolute...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992875/ https://www.ncbi.nlm.nih.gov/pubmed/29879915 http://dx.doi.org/10.1186/s12876-018-0797-8 |
_version_ | 1783330125105856512 |
---|---|
author | Huang, Bingsong Shi, Yi Liu, Jun Schroder, Paul M. Deng, Suxiong Chen, Maogen Li, Jun Ma, Yi Deng, Ronghai |
author_facet | Huang, Bingsong Shi, Yi Liu, Jun Schroder, Paul M. Deng, Suxiong Chen, Maogen Li, Jun Ma, Yi Deng, Ronghai |
author_sort | Huang, Bingsong |
collection | PubMed |
description | BACKGROUND: Portopulmonary hypertension (PPH) was once regarded as a contraindicaton to liver transplantation (LT). However, growing evidence has indicated that PPH patients undergoing LT may show similar outcomes compared to those without PPH, and researchers have recommended it not be an absolute contraindication. Given this controversy, we aimed to identify and review the current evidence on this topic and to provide a comparison of the outcomes after LT between candidates with PPH and those without. METHODS: We systematically searched the MEDLINE, EMBASE and Cochrane Library databases for all studies that compared the outcomes of PPH patients and those without PPH after LT. All studies reporting outcomes of PPH patients versus those without PPH (Control) were further considered for inclusion in this meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to compare the pooled data between PPH and Control groups. RESULTS: Eleven retrospective trials and one prospective, randomized, controlled trial, involving 37,686 transplant recipients were included. The PPH patients had increased 1-year mortality with an OR of 1.59 (95% CI = 1.26–2.01, P = 0.0001) compared to the control group. There was no significant difference in graft loss and 30-day mortality after LT between the two groups. CONCLUSIONS: Patients with PPH who underwent LT had increased 1-year mortality compared to those without PPH, while graft loss and 30-day mortality were similar. Nevertheless, LT may be a reasonable therapeutic option for some patients with PPH, but further studies are needed to identify those select patients with PPH who would benefit most from LT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0797-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5992875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59928752018-07-05 The early outcomes of candidates with portopulmonary hypertension after liver transplantation Huang, Bingsong Shi, Yi Liu, Jun Schroder, Paul M. Deng, Suxiong Chen, Maogen Li, Jun Ma, Yi Deng, Ronghai BMC Gastroenterol Research Article BACKGROUND: Portopulmonary hypertension (PPH) was once regarded as a contraindicaton to liver transplantation (LT). However, growing evidence has indicated that PPH patients undergoing LT may show similar outcomes compared to those without PPH, and researchers have recommended it not be an absolute contraindication. Given this controversy, we aimed to identify and review the current evidence on this topic and to provide a comparison of the outcomes after LT between candidates with PPH and those without. METHODS: We systematically searched the MEDLINE, EMBASE and Cochrane Library databases for all studies that compared the outcomes of PPH patients and those without PPH after LT. All studies reporting outcomes of PPH patients versus those without PPH (Control) were further considered for inclusion in this meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to compare the pooled data between PPH and Control groups. RESULTS: Eleven retrospective trials and one prospective, randomized, controlled trial, involving 37,686 transplant recipients were included. The PPH patients had increased 1-year mortality with an OR of 1.59 (95% CI = 1.26–2.01, P = 0.0001) compared to the control group. There was no significant difference in graft loss and 30-day mortality after LT between the two groups. CONCLUSIONS: Patients with PPH who underwent LT had increased 1-year mortality compared to those without PPH, while graft loss and 30-day mortality were similar. Nevertheless, LT may be a reasonable therapeutic option for some patients with PPH, but further studies are needed to identify those select patients with PPH who would benefit most from LT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0797-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-07 /pmc/articles/PMC5992875/ /pubmed/29879915 http://dx.doi.org/10.1186/s12876-018-0797-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Huang, Bingsong Shi, Yi Liu, Jun Schroder, Paul M. Deng, Suxiong Chen, Maogen Li, Jun Ma, Yi Deng, Ronghai The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title | The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title_full | The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title_fullStr | The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title_full_unstemmed | The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title_short | The early outcomes of candidates with portopulmonary hypertension after liver transplantation |
title_sort | early outcomes of candidates with portopulmonary hypertension after liver transplantation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992875/ https://www.ncbi.nlm.nih.gov/pubmed/29879915 http://dx.doi.org/10.1186/s12876-018-0797-8 |
work_keys_str_mv | AT huangbingsong theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT shiyi theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT liujun theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT schroderpaulm theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT dengsuxiong theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT chenmaogen theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT lijun theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT mayi theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT dengronghai theearlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT huangbingsong earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT shiyi earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT liujun earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT schroderpaulm earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT dengsuxiong earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT chenmaogen earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT lijun earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT mayi earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation AT dengronghai earlyoutcomesofcandidateswithportopulmonaryhypertensionafterlivertransplantation |